-
41.
公开(公告)号:US10927149B2
公开(公告)日:2021-02-23
申请号:US15773381
申请日:2016-10-26
Applicant: BIOLOGICAL E LIMITED
Inventor: Akshay Goel , Tushar Joglekar , Krishnanand Tiwari , Yogesh Mishra , Narender Dev Mantena , Mahima Datla
IPC: A61K39/00 , C12N15/70 , C07K1/18 , C07K14/005 , C07K1/113 , C07K14/195 , C07K1/12 , C07K14/22
Abstract: The present invention relates to a preparation method which is performed by expressing the recombinant carrier proteins in Escherichia coli and purification thereof. More particular, the invention relates to industrially scalable process for the recovery of recombinant carrier proteins.
-
公开(公告)号:US20210017222A1
公开(公告)日:2021-01-21
申请号:US17042872
申请日:2019-03-29
Applicant: AbbVie Inc.
Inventor: Anthony R Haight , Xiaoli Liao
Abstract: The present disclosure provides methods for selectively reducing an antibody, comprising contacting the antibody with a reducing agent selected from the group consisting of 2-[2-(Diphenylphosphino)ethyl]pyridine, 3-(Diphenylphosphino)benzenesulfonic acid, 4-(Diphenylphosphino)benzoic acid, 2-(Diphenylphosphino)ethylamine, 3-(diphenylphosphino)propylamine, 3-(Diphenylphosphino)propionic acid, 2-(diisopropylphosphino)ethylamine, 2-(diphenylphosphino)benzoic acid, (2-hydroxyphenyl)diphenylphosphine, and salts thereof. The present disclosure further provides methods of producing antibody conjugates, such as antibody-drug conjugates.
-
公开(公告)号:US20200347097A1
公开(公告)日:2020-11-05
申请号:US16781233
申请日:2020-02-04
Applicant: ONKURE, INC.
Inventor: Anthony D. Piscopio , Xiaoyong Fu , Feng Shi , Huayan Liu , Zhifeng Li
IPC: C07K11/02 , C07K5/097 , C07D498/06 , C07D513/06 , C07D513/14 , C07K11/00 , A61K38/15 , C07K1/113
Abstract: Processes for preparing compounds of Formula (1) and Formula (2) are described, wherein X, Y, Z, R1-R7, L and n are defined herein. Intermediates useful in the preparation of the compounds of Formula (1) and Formula (2) are also described.
-
公开(公告)号:US10822372B2
公开(公告)日:2020-11-03
申请号:US15563871
申请日:2016-03-30
Applicant: Roquette Freres
Inventor: Merveille Nono , Nicolas Descamps , Denis Simon , Olaf Haeusler
Abstract: One subject of the present invention is the use of a combination of a polyol (i) consisting of 12 carbon atoms and of a polyol (ii) consisting of 4 to 6 carbon atoms, as protein stabilizer. Another subject of the present invention is protein compositions comprising such a combination. A final subject of the present invention is a process for preparing protein compositions using such a combination.
-
公开(公告)号:US20200299402A1
公开(公告)日:2020-09-24
申请号:US16842864
申请日:2020-04-08
Applicant: GENZYME CORPORATION
Inventor: Kevin P. Brower , Chris Hwang , Rao Koduri , Konstantin B. Konstantinov , Veena Warikoo , Jin Yin , Marcella Yu
IPC: C07K16/28 , C07K16/00 , C07K1/113 , A61K39/395 , C07K16/22
Abstract: Disclosed herein are methods that have been developed to control the formation of disulfide bonds between polypeptides of a multimeric protein produced by a bioprocess. Also disclosed are protein solution parameters that allow for controlling the formation of disulfide bonds. In one example, the methods disclosed herein can be used to control the proportion of half antibody molecules in an antibody solution.
-
公开(公告)号:US10590407B2
公开(公告)日:2020-03-17
申请号:US15306249
申请日:2015-03-24
Applicant: NANYANG TECHNOLOGICAL UNIVERSITY
Inventor: Kien Truc Giang Nguyen , James P. Tam
Abstract: The present invention is directed to enzymes having Asx-specific ligase and cyclase activity and to nucleic acids encoding those as well as methods of the manufacture of said enzymes. Further encompassed are methods and uses of these enzymes.
-
公开(公告)号:US20200069811A1
公开(公告)日:2020-03-05
申请号:US16674099
申请日:2019-11-05
Inventor: Gary GELLERMAN
Abstract: A molecular structure comprising a targeting moiety, a multi-functional peptide platform and a plurality of controllably released bioactive agents attached thereto is provided herein.
-
公开(公告)号:US20190262501A1
公开(公告)日:2019-08-29
申请号:US16412884
申请日:2019-05-15
Applicant: Orthocell Pty Ltd.
Inventor: Ming Hao Zheng
Abstract: The present invention relates to a method of producing a collagen membrane that has particular mechanical properties. In particular, the present invention relates to a method A of producing a collagen membrane comprising the steps of (i) isolating a collagen-containing tissue and incubating same in an ethanol solution; (ii) incubating the collagen-containing tissue from step (i) in a first solution comprising an inorganic salt and an anionic surfactant in order to denature non-collagenous proteins contained therein; (iii) incubating the collagen-containing tissue produced in step (ii) in a second solution comprising an inorganic acid until the collagen in said material is denatured; and (iv) incubating the collagen-containing tissue produced in step (iii) in a third solution comprising an inorganic acid with simultaneous mechanical stimulation for sufficient time to enable the collagen bundles in said collagen-containing tissue to align; wherein the mechanical stimulation comprises applying tension cyclically to the collagen-containing tissue.
-
公开(公告)号:US10358475B1
公开(公告)日:2019-07-23
申请号:US15997728
申请日:2018-06-05
Applicant: Jose A. Lasalde-Dominicci , Orestes Quesada-Gonzalez , Josue Rodriguez-Cordero , Carlos Baez-Pagan
Inventor: Jose A. Lasalde-Dominicci , Orestes Quesada-Gonzalez , Josue Rodriguez-Cordero , Carlos Baez-Pagan
IPC: C30B29/54 , C07K14/705 , C07K1/113 , C12N9/54
Abstract: The invention is a high-throughput voltage screening crystallographic device and methodology that uses multiple micro wells and electric circuits capable of assaying different crystallization condition for the same or different proteins of interest at the same of different voltages under a humidity and temperature controlled environment. The protein is solubilized in a lipid matrix similar to the lipid composition of the protein in the native environment to ensure stability of the protein during crystallization. The invention provides a system and method where the protein is transferred to a lipid matrix that holds a resting membrane potential, which reduces the degree of conformational freedom of the protein. The invention overcomes the majority of the difficulties associated with vapor diffusion techniques and essentially reconstitutes the protein in its native lipid environment under “cuasi” physiological conditions.
-
公开(公告)号:US20190169230A1
公开(公告)日:2019-06-06
申请号:US16323247
申请日:2017-08-17
Applicant: ProZyme, Inc.
Inventor: Michael J. KIMZEY , Francis T. HAXO , Vaishali SHARMA
Abstract: Ammonium cation detergents comprising a quaternary or tertiary ammonium cation can be used as detergents to denature proteins and are particularly useful in denaturing glycoproteins or glycopeptides prior to enzymatic deglycosylation. Ammonium cation detergents with sulfate or sulfonate anions are particularly useful.
-
-
-
-
-
-
-
-
-